mardi 2 août 2016

Onco Actu du 2 août 2016

NB : la production d'Onco Actu s'interrompt aujourd'hui et reprendra à partir du 22 août.

1. Biologie

Targeting genes by the thousands [MIT News]

Taking aim at rare cancer variants [Broad Institute of MIT and Harvard]

5. Traitements

Stem Cells May Speed Up Screening of Drugs for Rare Cancers [Johns Hopkins]

Delivering Cancer Drugs to Tumor Blood Vessels [National Cancer Institute]

5.12.2 Immunothérapies - CAR-T

Setting the Body’s ‘Serial Killers’ Loose on Cancer [NY Times]

5.2 Pharma

Layoffs at Takeda [In the Pipeline]

Takeda and Seattle Genetics Announce Positive Data from Phase 3 ALCANZA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma [Takeda]

5.2.3 Pharma - économie

Celgene Accused of Using Charities ‘Scheme’ to Gain Billions [Bloomberg]

5.3 Traitements - FDA, EMA,...

EMA to Cut One Drug Division, Strengthen Collaborations With National Competent Authorities [RAPS]

Identifying opportunities for 'Big data' in medicines development and regulation [EMA]

Ireland calls for EU drug agency to be moved from London to Dublin [The Guardian]

6. Lutte contre les cancers

MD Anderson (Again) On Top of U.S. News and World Report Rankings [The Cancer Letter]

6.6 Publications

BMJ Open works with Publons to give credit for peer review [BMJ Blogs]

‘Kudos’ promises to help scientists promote their papers to new audiences [Nature News & Comment]

6.7 DMP, Big Data & applis

Introducing CancerBase: A Way To Share Personal Medical Data To Help Cancer Research [Scope Blog]

6.9 Controverses

Dispute over president's age tears Pasteur Institute apart [Science]